/Investor DB

Two Bear Capital — 2024 Investments

5 investments dated 2024 · listed companies and verified rows first · show all

Elisityelisity.comin𝕏Series A · Mar 2024 · $37M

Elisity provides an identity-based microsegmentation platform that turns existing network infrastructure (Cisco, Arista, Aruba, Juniper switches and Palo Alto firewalls) into policy enforcement points to discover devices and enforce least-privilege access without agents, new hardware, or re-IPing.

CybersecurityEnterprise SoftwareIoTSaaSSan Jose, US

Brian Thompson(Executive Officer)inJames Winebrenner(Executive Officer, Director)inBurjiz Pithawala(Founder)Srinivas Sardar(Founder)Sundher Narayan(Founder)

BoardBrian Long(Director)in

Board seatMichael Goguen· per SEC Form D

Co-investorsAllegisCyber CapitalAtlantic Bridge VenturesInsight PartnersRain CapitalALLEGIS CAPITALTCV

FYR Diagnosticsfyrdiagnostics.comin𝕏Aug 2024

BiotechMissoula, US

Brian Conway(Executive Officer)inChristopher Booth(Executive Officer, Director)Sarjubhai Patel(Executive Officer, Director)

Board seatAvery SonnenbergMichael Goguen· per SEC Form D

Binarlybinarly.ioin𝕏Seed · Mar 2024 · $11M

Binarly builds a binary-level product security platform that inspects compiled software, firmware, and binaries to validate SBOM/CBOM, detect tampering, secrets, and malicious code, prioritize exploitable vulnerabilities, and assess post-quantum cryptography readiness.

AI & Machine LearningCybersecurityDeveloper ToolsSanta Monica, US

Alex Matrosov(Founder)inAlex Matrosov Claudiu Teodorescu(Founder)

Co-investorsCanaan PartnersCisco InvestmentsOlive Tree CapitalStoneMill VenturesBlu Venture InvestorsEmerging Ventures

Dymiumdymium.ioinSeed · Mar 2024 · $7M

Dymium is a data-centric, zero-trust platform that governs access to enterprise data in real time, applying identity-, role-, and context-based policies before data is returned.

AI & Machine LearningCybersecurityData & InfrastructureLos Gatos, US

Valentyn Kamyshenko(Founder)in

Co-investorsSINEWAVE VENTURES

Talus Biotalus.bioin𝕏Seed · Jul 2024

Talus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts.

AI & Machine LearningBiotechDeep TechHealthtechSeattle, US

Alex Federation(Founder)inLindsay Pino(Founder)inAlex Federation, Ph.D.(Chief Executive Officer & Co-Founder)Lindsay Pino, Ph.D.(Chief Technology Officer & Co-Founder)

BoardOmri Amirav-Drory(Director)inJ. Seth Strattan(Director)in

Co-investorsFarvatn VentureFifty YearsFundersClubGaingelsJude GomilaNFX+12 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.